Trial Profile
Single dose cardiovascular study of glycopyrrolate/indacaterol (QVA-149) in healthy subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2015
Price :
$35
*
At a glance
- Drugs Glycopyrrolate/indacaterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- Sponsors Novartis
- 10 Aug 2015 New trial record